5-(benzimidazol-1-yl)-N-(4-piperazin-1-yl-3-pyridinyl)-1,3-oxazole-2-carboxamide;5-[3-(3-methoxyphenyl)-2-oxoimidazolidin-1-yl]-N-(4-piperazin-1-yl-3-pyridinyl)-1,3-oxazole-2-carboxamide;bis(5-[4-(3-methoxyphenyl)-2-oxopyrrolidin-1-yl]-N-(4-piperazin-1-yl-3-pyridinyl)-1,3-oxazole-2-carboxamide);5-[3-(2-morpholin-4-ylethyl)-2-oxobenzimidazol-1-yl]-N-(4-piperazin-1-yl-3-pyridinyl)-1,3-oxazole-2-carboxamide;5-(4-phenylpiperidin-1-yl)-N-(4-piperazin-1-yl-3-pyridinyl)-1,3-oxazole-2-carboxamide
C141H154N40O20 — CID 162054387
Data last refreshed: (MolForge compound catalog, from PubChem)
About 5-(benzimidazol-1-yl)-N-(4-piperazin-1-yl-3-pyridinyl)-1,3-oxazole-2-carboxamide;5-[3-(3-methoxyphenyl)-2-oxoimidazolidin-1-yl]-N-(4-piperazin-1-yl-3-pyridinyl)-1,3-oxazole-2-carboxamide;bis(5-[4-(3-methoxyphenyl)-2-oxopyrrolidin-1-yl]-N-(4-piperazin-1-yl-3-pyridinyl)-1,3-oxazole-2-carboxamide);5-[3-(2-morpholin-4-ylethyl)-2-oxobenzimidazol-1-yl]-N-(4-piperazin-1-yl-3-pyridinyl)-1,3-oxazole-2-carboxamide;5-(4-phenylpiperidin-1-yl)-N-(4-piperazin-1-yl-3-pyridinyl)-1,3-oxazole-2-carboxamide
5-(benzimidazol-1-yl)-N-(4-piperazin-1-yl-3-pyridinyl)-1,3-oxazole-2-carboxamide;5-[3-(3-methoxyphenyl)-2-oxoimidazolidin-1-yl]-N-(4-piperazin-1-yl-3-pyridinyl)-1,3-oxazole-2-carboxamide;bis(5-[4-(3-methoxyphenyl)-2-oxopyrrolidin-1-yl]-N-(4-piperazin-1-yl-3-pyridinyl)-1,3-oxazole-2-carboxamide);5-[3-(2-morpholin-4-ylethyl)-2-oxobenzimidazol-1-yl]-N-(4-piperazin-1-yl-3-pyridinyl)-1,3-oxazole-2-carboxamide;5-(4-phenylpiperidin-1-yl)-N-(4-piperazin-1-yl-3-pyridinyl)-1,3-oxazole-2-carboxamide (PubChem CID 162054387) has the molecular formula C141H154N40O20 and a molecular weight of 2729.04 g/mol. Its IUPAC name is 5-(benzimidazol-1-yl)-N-(4-piperazin-1-yl-3-pyridinyl)-1,3-oxazole-2-carboxamide;5-[3-(3-methoxyphenyl)-2-oxoimidazolidin-1-yl]-N-(4-piperazin-1-yl-3-pyridinyl)-1,3-oxazole-2-carboxamide;bis(5-[4-(3-methoxyphenyl)-2-oxopyrrolidin-1-yl]-N-(4-piperazin-1-yl-3-pyridinyl)-1,3-oxazole-2-carboxamide);5-[3-(2-morpholin-4-ylethyl)-2-oxobenzimidazol-1-yl]-N-(4-piperazin-1-yl-3-pyridinyl)-1,3-oxazole-2-carboxamide;5-(4-phenylpiperidin-1-yl)-N-(4-piperazin-1-yl-3-pyridinyl)-1,3-oxazole-2-carboxamide.
Molecular Properties
| Compound Name | 5-(benzimidazol-1-yl)-N-(4-piperazin-1-yl-3-pyridinyl)-1,3-oxazole-2-carboxamide;5-[3-(3-methoxyphenyl)-2-oxoimidazolidin-1-yl]-N-(4-piperazin-1-yl-3-pyridinyl)-1,3-oxazole-2-carboxamide;bis(5-[4-(3-methoxyphenyl)-2-oxopyrrolidin-1-yl]-N-(4-piperazin-1-yl-3-pyridinyl)-1,3-oxazole-2-carboxamide);5-[3-(2-morpholin-4-ylethyl)-2-oxobenzimidazol-1-yl]-N-(4-piperazin-1-yl-3-pyridinyl)-1,3-oxazole-2-carboxamide;5-(4-phenylpiperidin-1-yl)-N-(4-piperazin-1-yl-3-pyridinyl)-1,3-oxazole-2-carboxamide |
|---|---|
| PubChem CID | 162054387 |
| Molecular Formula | C141H154N40O20 |
| Molecular Weight | 2729.04 g/mol |
| Exact Mass | 2727.23 |
| IUPAC Name | 5-(benzimidazol-1-yl)-N-(4-piperazin-1-yl-3-pyridinyl)-1,3-oxazole-2-carboxamide;5-[3-(3-methoxyphenyl)-2-oxoimidazolidin-1-yl]-N-(4-piperazin-1-yl-3-pyridinyl)-1,3-oxazole-2-carboxamide;bis(5-[4-(3-methoxyphenyl)-2-oxopyrrolidin-1-yl]-N-(4-piperazin-1-yl-3-pyridinyl)-1,3-oxazole-2-carboxamide);5-[3-(2-morpholin-4-ylethyl)-2-oxobenzimidazol-1-yl]-N-(4-piperazin-1-yl-3-pyridinyl)-1,3-oxazole-2-carboxamide;5-(4-phenylpiperidin-1-yl)-N-(4-piperazin-1-yl-3-pyridinyl)-1,3-oxazole-2-carboxamide |
| SMILES | COc1cccc(C2CC(=O)N(c3cnc(C(=O)Nc4cnccc4N4CCNCC4)o3)C2)c1.COc1cccc(C2CC(=O)N(c3cnc(C(=O)Nc4cnccc4N4CCNCC4)o3)C2)c1.COc1cccc(N2CCN(c3cnc(C(=O)Nc4cnccc4N4CCNCC4)o3)C2=O)c1.O=C(Nc1cnccc1N1CCNCC1)c1ncc(-n2c(=O)n(CCN3CCOCC3)c3ccccc32)o1.O=C(Nc1cnccc1N1CCNCC1)c1ncc(-n2cnc3ccccc32)o1.O=C(Nc1cnccc1N1CCNCC1)c1ncc(N2CCC(c3ccccc3)CC2)o1 |
| InChI | InChI=1S/C26H30N8O4.2C24H26N6O4.C24H28N6O2.C23H25N7O4.C20H19N7O2/c35-24(30-19-17-28-6-5-20(19)32-9-7-27-8-10-32)25-29-18-23(38-25)34-22-4-2-1-3-21(22)33(26(34)36)12-11-31-13-15-37-16-14-31;2*1-33-18-4-2-3-16(11-18)17-12-21(31)30(15-17)22-14-27-24(34-22)23(32)28-19-13-26-6-5-20(19)29-9-7-25-8-10-29;31-23(28-20-16-26-9-6-21(20)29-14-10-25-11-15-29)24-27-17-22(32-24)30-12-7-19(8-13-30)18-4-2-1-3-5-18;1-33-17-4-2-3-16(13-17)29-11-12-30(23(29)32)20-15-26-22(34-20)21(31)27-18-14-25-6-5-19(18)28-9-7-24-8-10-28;28-19(25-15-11-22-6-5-16(15)26-9-7-21-8-10-26)20-23-12-18(29-20)27-13-24-14-3-1-2-4-17(14)27/h1-6,17-18,27H,7-16H2,(H,30,35);2*2-6,11,13-14,17,25H,7-10,12,15H2,1H3,(H,28,32);1-6,9,16-17,19,25H,7-8,10-15H2,(H,28,31);2-6,13-15,24H,7-12H2,1H3,(H,27,31);1-6,11-13,21H,7-10H2,(H,25,28) |
| InChIKey | YYZFADWUIFWXDS-UHFFFAOYSA-N |
| XLogP | 13.06 |
| TPSA | 652.06 Ų |
| H-Bond Donors | 12 |
| H-Bond Acceptors | 50 |
| Rotatable Bonds | 34 |
| Heavy Atoms | 201 |
| Complexity | — |
Lipinski Rule of Five
4 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 2729.04 |
| LogP ≤ 5 | 13.06 |
| H-Bond Donors ≤ 5 | 12 |
| H-Bond Acceptors ≤ 10 | 50 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 162054387 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.